栄研化学(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4549/E00961 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/07/04 | 日証協 | 101,153株 | -0.58% | 18,784株 | +1478.49% | 151,011株 | -4.36% | 1,710株 | -46.56% |
| 2014/06/27 | 日証協 | 101,743株 | -4.15% | 1,190株 | -93.16% | 157,901株 | +2.27% | 3,200株 | -94.9% |
| 2014/06/20 | 日証協 | 106,153株 | -1.57% | 17,403株 | -3.33% | 154,401株 | -0.32% | 62,790株 | +2234.2% |
| 2014/06/13 | 日証協 | 107,843株 | -0.19% | 18,003株 | +2150.38% | 154,901株 | -4.62% | 2,690株 | +2590% |
| 2014/06/06 | 日証協 | 108,053株 | +0.56% | 800株 | -96.3% | 162,411株 | -0.61% | 100株 | -98.78% |
| 2014/05/30 | 日証協 | 107,453株 | +9.14% | 21,600株 | +29.32% | 163,411株 | +3.68% | 8,200株 | +1540% |
| 2014/05/23 | 日証協 | 98,453株 | +1.65% | 16,703株 | +227.51% | 157,611株 | 0% | 500株 | -90.38% |
| 2014/05/16 | 日証協 | 96,853株 | -3.97% | 5,100株 | +628.57% | 157,611株 | -5.8% | 5,200株 | 0% |
| 2014/05/09 | 日証協 | 100,853株 | -5.44% | 700株 | -71.21% | 167,311株 | -3.91% | 0株 | -100% |
| 2014/05/02 | 日証協 | 106,653株 | -10.11% | 2,431株 | -56.91% | 174,111株 | -16.38% | 200株 | -93.55% |
| 2014/04/25 | 日証協 | 118,653株 | -5.87% | 5,642株 | -62.39% | 208,212株 | -2.44% | 3,101株 | +106.73% |
| 2014/04/18 | 日証協 | 126,053株 | -21.1% | 15,003株 | +5.63% | 213,411株 | -23.29% | 1,500株 | -97.4% |
| 2014/04/11 | 日証協 | 159,753株 | -8.53% | 14,203株 | +9.61% | 278,216株 | -2.83% | 57,790株 | -19.52% |
| 2014/04/04 | 日証協 | 174,650株 | +60.89% | 12,958株 | -35.2% | 286,313株 | +81.2% | 71,805株 | +423.97% |
| 2014/03/28 | 日証協 | 108,550株 | -10.92% | 19,997株 | -73.58% | 158,007株 | -35.01% | 13,704株 | -94.01% |
| 2014/03/20 | 日証協 | 121,853株 | +97.32% | 75,700株 | +350.6% | 243,111株 | +249.24% | 228,700株 | +9999.99% |
| 2014/03/14 | 日証協 | 61,753株 | -2.98% | 16,800株 | -25.18% | 69,611株 | -7.2% | 1,000株 | -77.27% |
| 2014/03/07 | 日証協 | 63,653株 | +12.75% | 22,455株 | +148.26% | 75,011株 | -0.06% | 4,400株 | -20% |
| 2014/02/28 | 日証協 | 56,453株 | +1.26% | 9,045株 | +249.23% | 75,056株 | +0.13% | 5,500株 | -41.77% |
※株式分割は考慮していませんのでご注意ください。
Page Top